Dillon & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.75M | Sell |
|
|||||
|
2025
Q2 | $7.01M | Sell |
|
|||||
|
2025
Q1 | $8.71M | Sell |
|
|||||
|
2024
Q4 | $9.9M | Buy |
|
|||||
|
2024
Q3 | $14.2M | Buy |
|
|||||
|
2024
Q2 | $13.3M | Buy |
|
|||||
|
2024
Q1 | $11.9M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Sell |
|
|||||
|
2023
Q3 | $9.99M | Buy |
|
|||||
|
2023
Q2 | $8.46M | Buy |
|
|||||
|
2023
Q1 | $8.94M | Buy |
|
|||||
|
2022
Q4 | $7.59M | Sell |
|
|||||
|
2022
Q3 | $7.25M | Buy |
|
|||||
|
2022
Q2 | $5.96M | Buy |
|
|||||
|
2022
Q1 | $6.79M | Buy |
|
|||||
|
2021
Q4 | $5.83M | Buy |
|
|||||
|
2021
Q3 | $4.75M | Buy |
|
|||||
|
2021
Q2 | $3.56M | Buy |
|
|||||
|
2021
Q1 | $1.67M | Buy |
|